SMAD4 and cancer: However, Smad4 is also known to be inactivated in more than 50% of PDAC patients, and several in vitro studies have indicated that both AsPC1 and BxPC3 lack Smad4 protein expression [61,62,63,64,65], therefore its contribution to signal transduction is negligible in regards to these particular cancer cell lines.